Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Transmembrane serine protease 7 (TMPRSS7, also known as matriptase-3) is a membrane-anchored serine protease belonging to the type II transmembrane serine protease (TTSP) family[1][2][5][6]. It is composed of several protein domains, including a transmembrane domain and a C-terminal serine protease domain. TMPRSS7 is phylogenetically conserved across vertebrates and is predominantly expressed in brain, skin, reproductive, and oropharyngeal tissues[2]. Functionally, TMPRSS7 catalyzes protein and peptide hydrolysis with a preference for arginine in the substrate's P1 position and participates in proteolytic processes at the cell surface. TMPRSS7 genetic variants have been linked to increased risk and poorer prognosis in breast cancer, suggesting a role in modulating tumor microenvironment and cancer progression[1]. TMPRSS7 is therefore considered a potential biomarker and putative therapeutic target in oncology, though targeted drugs have not yet been reported.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Transmembrane serine protease 7 (TMPRSS7).